Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
72°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cannapharmarx Inc
(OP:
CPMD
)
0.0140
UNCHANGED
Last Price
Updated: 1:10 PM EDT, Jul 21, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cannapharmarx Inc
CannaPharmaRx Expands Board of Directors
August 25, 2023
Via
ACCESSWIRE
CannaPharmaRx Appoints Dean Medwid as New CEO
June 23, 2023
Via
ACCESSWIRE
CannaPharmaRx Signs Agreement with Nasha Genetics
April 19, 2023
Via
ACCESSWIRE
CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis
March 30, 2023
Via
ACCESSWIRE
CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website
March 21, 2023
Via
ACCESSWIRE
CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company
February 21, 2023
Via
ACCESSWIRE
CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock
February 01, 2023
Via
ACCESSWIRE
CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023
January 30, 2023
Via
ACCESSWIRE
CannaPharmaRx Receives Canada Revenue Agency (CRA) License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected
January 11, 2023
Via
ACCESSWIRE
Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond
December 22, 2022
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - December 22, 2022) - Investorideas.com, a leading investor news resource covering cannabis...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million
December 21, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Cannabis
Exposures
Cannabis
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million
December 21, 2022
Via
ACCESSWIRE
Cannabis Cultivation Revenue Continues to Climb as Demand & Usage Grows Across North America
December 21, 2022
EQNX::TICKER_START (OTCPK:CPMD),(OTCQX:TCNNF),(OTCQX:CURLF),(NASDAQ:TLRY),(NASDAQ:ACB) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Cannabis
Derivatives
Exposures
COVID-19
Cannabis
Derivatives
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million
December 21, 2022
Calgary, AB – December 21, 2022 – CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today it received its cultivation...
Via
FinancialNewsMedia
Topics
Cannabis
Exposures
Cannabis
CannaPharmaRx Secures New Strains for Declaration to be Incorporated Into Product Portfolio
December 19, 2022
Calgary, AB – December 19, 2022 – CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today it has secured new genetic strains...
Via
FinancialNewsMedia
Topics
Cannabis
Exposures
Cannabis
CannaPharmaRx Secures New Strains for Declaration to be Incorporated Into Product Portfolio
December 19, 2022
Via
ACCESSWIRE
CannaPharmaRx Files Response with Health Canada in Preparation for Cremona Facility Opening
September 07, 2022
Via
ACCESSWIRE
CannaPharmaRx Signs Collaboration and Offtake Agreement with Spring Medical Group for Up to $12 Million of Commercial Cannabis
August 24, 2022
Via
ACCESSWIRE
CannaPharmaRx Enters into a Genetics Transfer Agreement with High Profile Cannabis Corp.
June 29, 2022
CALGARY, AB / ACCESSWIRE / June 29, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a...
From
CannaPharmaRx
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
CannaPharmaRx Acquiring Oklahoma Cannabis Facility
February 10, 2022
CALGARY, AB / ACCESSWIRE / February 10, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a...
From
CannaPharmaRx
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
CannaPharmaRx Stops Issuing Shares Under Previously Effective S-1
February 08, 2022
CALGARY, AB / ACCESSWIRE / February 8, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today that it...
From
CannaPharmaRx
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
CannaPharmaRx Enters into an Agreement for Supply of Genetics and Feed Stock to Accelerate Time to Market
January 25, 2022
CALGARY, AB / ACCESSWIRE / January 25, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today they have...
From
CannaPharmaRx
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
CannaPharmaRx Hires Key Personnel to Accelerate Output and Speed to Market for Cannabis Product
January 19, 2022
CALGARY, AB / ACCESSWIRE / January 19, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today the hiring...
From
CannaPharmaRx
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
CannaPharmaRx Completes Long Term Lease for Cremona Production Facility Which Should Yield 6,000Kg ($30,000,000)/Year
January 06, 2022
CALGARY, AB / ACCESSWIRE / January 6, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today the...
From
CannaPharmaRx
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
CannaPharmaRX, Inc. Closes Sale of Hanover Facility for $2,000,000 CAD
July 13, 2021
CALGARY, AB / ACCESSWIRE / July 13, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today the sale of...
From
CannaPharmaRx
Via
AccessWire
Topics
Cannabis
Energy
Exposures
Cannabis
Electricity Generation
CannaPharmaRx Comments on Stock Promotion Flag
June 24, 2021
CALGARY, AB / ACCESSWIRE / June 24, 2021 / CannaPharmaRx, Inc. (OTC PINK:CPMD) a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced that it has been...
From
CannaPharmaRx
Via
AccessWire
Topics
Cannabis
Energy
Regulatory Compliance
Exposures
Cannabis
Electricity Generation
Legal
CannaPharmaRX, Inc. Signs Agreement with Israeli Group K&K Consulting
June 16, 2021
Agreement Provides Exposure to Israeli Medicinal Cannabis Market CALGARY, AB / ACCESSWIRE / June 16, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient...
From
CannaPharmaRx
Via
AccessWire
Topics
Cannabis
Energy
Exposures
Cannabis
Electricity Generation
CannaPharmaRX, Inc. Sells Hanover Facility for $2,000,000 CAD
June 08, 2021
CALGARY, AB / ACCESSWIRE / June 8, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today it is selling...
From
CannaPharmaRx
Via
AccessWire
Topics
Cannabis
Energy
Exposures
Cannabis
Electricity Generation
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.